Archive

ClinicalClinical
+2+2
🍜Device Exempt from Clinical Evaluation?

🍜Device Exempt from Clinical Evaluation?

Elaine Tan
ClinicalClinical
+2+2
Entering the China Market: Clinical Trial vs Clinical Trial Exemption

Entering the China Market: Clinical Trial vs Clinical Trial Exemption

Elaine Tan
RegistrationRegistration
+1+1
🍜 Navigating the NMPA Registration Process: Timelines, Costs, and Considerations

🍜 Navigating the NMPA Registration Process: Timelines, Costs, and Considerations

Elaine Tan
China AgentChina Agent
+1+1
🍜 Potential Changes to the In-Country Agent Role in China in 2025

🍜 Potential Changes to the In-Country Agent Role in China in 2025

Elaine Tan
China AgentChina Agent
+1+1
Qualifications of an Authorized Representative in China

Qualifications of an Authorized Representative in China

Elaine Tan
Medical DeviceMedical Device
+1+1
Unable to identify the risk class or product category?

Unable to identify the risk class or product category?

Elaine Tan
Medical DeviceMedical Device
+1+1
Classification of Medical Devices in China

Classification of Medical Devices in China

Elaine Tan
Medical DeviceMedical Device
+1+1
Is my product considered a medical device in China?

Is my product considered a medical device in China?

Elaine Tan
FirstBack
123
Next Last